Senior insider sale
Global Quality Officer at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$427.7K
24.68K shares
What this filing means
SHANNON ELAINE MARY plans to sell 24.68K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $427.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/10/2026ACC: 0001493152-26-036878
Officer· Global Quality Officer
Since Mar 2026
24.68K
Shares to sell
$427.7K
Approx. market value
28.78K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Restricted Stock Unit Awards - Vested
Compensation
7/30/2024
14.94KRestricted Stock Unit Awards - Vested
Compensation
7/28/2023
13.84KTotal acquired28.78K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/30/2024 | Restricted Stock Unit Awards - Vested Compensation | 14.94K | — |
7/28/2023 | Restricted Stock Unit Awards - Vested Compensation | 13.84K | — |
| Total | 28.78K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.32K
Market value
$72.4K
7/13/2026
Planned — Approximate Date
NYSEPlanned
Units to sell
20.36K
Market value
$355.3K
8/11/2026
Total
Units
24.68K
Value
$427.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/13/2026 | 4.32K | $72.4K | — | Completed |
| Planned — Approximate Date | ||||
8/11/2026 | 20.36K | $355.3K | NYSE | Planned |
| Total | 24.68K | $427.7K | ||